Delivery Order SPE2DX22D0049-SPE2D826FA1LF
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $35,100.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 3, 2025, with an ultimate completion date of November 4, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,123.51 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 3, 2025, with an ultimate completion date of November 4, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract is...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,177.85 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 3, 2025, with an ultimate completion date of November 4, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,267.90 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 5, 2025, with completion scheduled for November 6, 2025. This firm fixed-price delivery order, which received no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $16,363.25 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 10, 2025, with completion scheduled for November 12, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $17,967.81 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 5, 2025, with an ultimate completion date of July 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal healthcare vendor,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $14,013.99 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The work will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,410.62 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), headquartered in Conshohocken, Pennsylvania, on November 3, 2025, with completion expected by November 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. The company serves as a critical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,779.20 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on June 21, 2025, with an ultimate completion date of June 23, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,367.90 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA1LFDelivery Order
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $36,140.72 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 10, 2025, with completion scheduled for November 12, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a critical pharmaceutical and medical supply distributor for federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen supplies a comprehensive portfolio of medical products to support military and veteran healthcare needs, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The broader SPE2DX IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply critical medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order carries no set-aside designation, reflecting the company's demonstrated capability to compete successfully in open federal procurement for medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.1k | 11/10/25 |